Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Insurer Aviva looking to sell Asia business - sources

Published 01/08/2019, 14:28
Updated 01/08/2019, 14:31
© Reuters.  Insurer Aviva looking to sell Asia business - sources

HONG KONG/LONDON (Reuters) - British life and general insurer Aviva (L:AV) is looking to sell its Asia business, valuing the unit at more than $2 billion (£1.65 billion), two sources familiar with the matter told Reuters.

Aviva is working with a financial adviser on a possible sale, with a formal process likely to begin in the fourth quarter, the sources said.

There is no certainty of a sale, which will depend on the outcome of a review of the Asian business to be completed by the end of this quarter, the sources said.

Aviva declined to comment.

Aviva is expected to go through an overhaul after appointing insider Maurice Tulloch as chief executive in March, but has not yet detailed many of its plans.

It announced a restructuring of its UK operations in June, aiming to save 300 million pounds ($362.82 million) a year in costs.

It reports half-year results on Aug 8 and has said it will update the market further at an investor day in November.

Aviva's six Asian businesses - China, Hong Kong, India, Indonesia, Singapore and Vietnam - posted a 26% rise in operating profit in 2018 to 284 million pounds. Only Singapore and Vietnam are wholly-owned businesses, with Singapore contributing nearly half of the Asia unit's operating profit.

Asia is a promising market for global insurers due to low penetration of insurance and fast-growing economies, but some have struggled to scale up in tough competition with larger regional players including AIA Group (HK:1299) and bigger global peers such as Prudential (L:PRU).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Regulatory restrictions on ownership in some markets such as China and India have also been an overhang.

Bloomberg reported earlier on Thursday that Aviva was planning to sell the Asian unit.

A sale "would be a step in the right direction" to improving the structure of Aviva's business and would likely net the insurer around 1.5-2 billion pounds ($1.82-2.42 billion), JPMorgan (NYSE:JPM) analysts said in a note.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.